Puzio Claire E, Rudloff Elke, Pigott Armi M
Department of Emergency and Critical Care, BluePearl Specialty and Emergency Pet Hospital, Glendale, Wisconsin, USA.
J Vet Emerg Crit Care (San Antonio). 2023 Jul-Aug;33(4):442-446. doi: 10.1111/vec.13315. Epub 2023 Jul 12.
To determine whether administration of antiemetic medication to dogs and cats with gastrointestinal foreign body obstruction (GIFBO) delays time to definitive care (surgery or endoscopy) and increases the risk of complications.
Retrospective study (January 2012-July 2020).
Private referral center.
Five hundred and thirty-seven (440 dogs and 97 cats).
None.
Medical records of dogs and cats with GIFBO were reviewed for antiemetic administration at the onset of clinical signs, time from onset of clinical signs to first intervention and definitive care, GIFBO-related complications, and length of hospitalization. Antiemetics were prescribed for 200 of 537 patients (158 dogs, 42 cats). Antiemetic administration was associated with an increased time between the onset of clinical signs and definitive care (3.2 days [95% confidence interval, CI, 2.8-3.5] vs. 1.6 days [95% CI, 1.4-2.0]; P < 0.001) but not with GIFBO-associated complications (P = 0.45). Antiemetic administration was associated with an increased length of hospitalization (1.6 days [95% CI, 1.4-1.7] vs. 1.1 days [95% CI, 1.1-1.2]; P < 0.001). A longer duration of clinical signs prior to intervention was associated with GIFBO-related complications (P < 0.001) regardless of antiemetic administration.
Antiemetic administration in patients with GIFBO was associated with increased time to definitive care and length of hospitalization but not GIFBO-associated complications. Antiemetics are not inherently contraindicated in patients for whom GIFBO is a differential, but clients should be counseled to monitor for progression of clinical signs and follow-up accordingly.
确定对患有胃肠道异物梗阻(GIFBO)的犬猫使用止吐药物是否会延迟至确定性治疗(手术或内窥镜检查)的时间,并增加并发症风险。
回顾性研究(2012年1月至2020年7月)。
私立转诊中心。
537只(440只犬和97只猫)。
无。
回顾患有GIFBO的犬猫的病历,记录临床症状出现时使用止吐药物的情况、从临床症状出现到首次干预和确定性治疗的时间、与GIFBO相关的并发症以及住院时间。537例患者中有200例(158只犬,42只猫)使用了止吐药物。使用止吐药物与临床症状出现至确定性治疗之间的时间增加有关(3.2天[95%置信区间,CI,2.8 - 3.5]对比1.6天[95%CI,1.4 - 2.0];P < 0.001),但与GIFBO相关并发症无关(P = 0.45)。使用止吐药物与住院时间延长有关(1.6天[95%CI,1.4 - 1.7]对比1.1天[95%CI,1.1 - 1.2];P < 0.001)。无论是否使用止吐药物,干预前临床症状持续时间较长与GIFBO相关并发症有关(P < 0.001)。
GIFBO患者使用止吐药物与至确定性治疗的时间增加和住院时间延长有关,但与GIFBO相关并发症无关。对于GIFBO为鉴别诊断的患者,并非绝对禁忌使用止吐药物,但应建议客户监测临床症状的进展并相应地进行随访。